Linda Hogarth

845 total citations
29 papers, 666 citations indexed

About

Linda Hogarth is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Linda Hogarth has authored 29 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in Linda Hogarth's work include Acute Lymphoblastic Leukemia research (11 papers), Glutathione Transferases and Polymorphisms (4 papers) and Sulfur Compounds in Biology (4 papers). Linda Hogarth is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Glutathione Transferases and Polymorphisms (4 papers) and Sulfur Compounds in Biology (4 papers). Linda Hogarth collaborates with scholars based in United Kingdom, United States and Japan. Linda Hogarth's co-authors include Andrew G. Hall, Sally A. Coulthard, Elizabeth Matheson, Lynne Minto, Marian Case, Christopher P.F. Redfern, Julie Irving, Nick Bown, Valérie Bergoglio and Jean‐Sèbastien Hoffmann and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Linda Hogarth

27 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Hogarth United Kingdom 14 387 232 152 91 82 29 666
Alissa K. Robbins United States 12 286 0.7× 272 1.2× 239 1.6× 242 2.7× 100 1.2× 19 919
Angelo B. A. Laranjeira United States 14 325 0.8× 133 0.6× 140 0.9× 171 1.9× 64 0.8× 35 620
Katharine H. Dixon United States 8 360 0.9× 144 0.6× 333 2.2× 84 0.9× 26 0.3× 8 876
D. M. Moccio United States 16 393 1.0× 289 1.2× 260 1.7× 133 1.5× 43 0.5× 21 920
O Babuŝíková Slovakia 11 339 0.9× 117 0.5× 132 0.9× 184 2.0× 117 1.4× 83 677
Yuri Yanishevski United States 13 296 0.8× 517 2.2× 183 1.2× 220 2.4× 36 0.4× 15 860
WR Vogler United States 12 286 0.7× 167 0.7× 133 0.9× 243 2.7× 47 0.6× 20 588
Carol A. Cucchi United States 11 445 1.1× 97 0.4× 310 2.0× 84 0.9× 92 1.1× 15 734
Aglair B. Garcia Brazil 15 212 0.5× 76 0.3× 144 0.9× 189 2.1× 33 0.4× 30 545
Sita Kugel Desmoulin United States 12 450 1.2× 75 0.3× 91 0.6× 74 0.8× 40 0.5× 12 692

Countries citing papers authored by Linda Hogarth

Since Specialization
Citations

This map shows the geographic impact of Linda Hogarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Hogarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Hogarth more than expected).

Fields of papers citing papers by Linda Hogarth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Hogarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Hogarth. The network helps show where Linda Hogarth may publish in the future.

Co-authorship network of co-authors of Linda Hogarth

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Hogarth. A scholar is included among the top collaborators of Linda Hogarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Hogarth. Linda Hogarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gault, Abigail, Linda Hogarth, Alastair Greystoke, et al.. (2024). Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study. BMC Cancer. 24(1). 733–733. 5 indexed citations
2.
Plummer, Ruth, et al.. (2023). Impact of an educational intervention for advanced cancer patients referred for early phase clinical trials. British Journal of Nursing. 32(15). 748–753.
3.
Rae, S., E. Ruth Plummer, Linda Hogarth, et al.. (2023). Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders. Journal of Cancer Research and Clinical Oncology. 149(18). 16355–16363. 1 indexed citations
4.
Hogarth, Linda, Miranda Patterson, David Jamieson, et al.. (2017). P2.01-070 Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S829–S830.
5.
Deva, Sanjeev, Richard D. Baird, Nicola Cresti, et al.. (2015). Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.. Journal of Clinical Oncology. 33(15_suppl). 2511–2511. 5 indexed citations
6.
Davies, Carwyn, Linda Hogarth, Karen L. MacKenzie, Andrew G. Hall, & Richard B. Lock. (2015). p21WAF1modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia. Cell Cycle. 14(22). 3602–3612. 9 indexed citations
7.
Spicer, James, Richard D. Baird, Aneta Suder, et al.. (2014). Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours. European Journal of Cancer. 51(2). 137–145. 13 indexed citations
8.
Davies, Carwyn, Linda Hogarth, Petra Bachmann, et al.. (2011). p53-independent Epigenetic Repression of the p21WAF1 Gene in T-cell Acute Lymphoblastic Leukemia. Journal of Biological Chemistry. 286(43). 37639–37650. 20 indexed citations
9.
Hogarth, Linda, Christopher P.F. Redfern, Jens M. Teodoridis, et al.. (2008). The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Biochemical Pharmacology. 76(8). 1024–1035. 27 indexed citations
10.
Matheson, Elizabeth, Linda Hogarth, Marian Case, Julie Irving, & Andrew G. Hall. (2006). DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo. Carcinogenesis. 28(6). 1341–1346. 10 indexed citations
11.
Coulthard, Sally A. & Linda Hogarth. (2005). The thiopurines: An update. Investigational New Drugs. 23(6). 523–532. 95 indexed citations
12.
13.
Hogarth, Linda, et al.. (2004). Old Drugs-Current Perspectives. 2(2). 163–173. 3 indexed citations
14.
Hogarth, Linda, et al.. (2003). Measurement of Reduced Glutathione Using High-Pressure Liquid Chromatography. Humana Press eBooks. 28. 91–94. 1 indexed citations
15.
Coulthard, Sally A., Linda Hogarth, Elizabeth Matheson, et al.. (2002). The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs. Molecular Pharmacology. 62(1). 102–109. 71 indexed citations
16.
Bergoglio, Valérie, Yvan Canitrot, Linda Hogarth, et al.. (2001). Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene. 20(43). 6181–6187. 78 indexed citations
17.
Masters, John R., Richard Thomas, Andrew G. Hall, et al.. (1996). Sensitivity of testis tumour cells to chemotherapeutic drugs: Role of detoxifying pathways. European Journal of Cancer. 32(7). 1248–1253. 55 indexed citations
18.
Hogarth, Linda, Martin English, L Price, et al.. (1996). The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine. Cancer Chemotherapy and Pharmacology. 37(5). 479–485. 8 indexed citations
19.
Rowe, David W., et al.. (1996). A case of mature B‐cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene. British Journal of Haematology. 94(1). 133–135. 9 indexed citations
20.
Ghazal‐Aswad, Saad, Linda Hogarth, Andrew G. Hall, et al.. (1996). The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients. British Journal of Cancer. 74(3). 468–473. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alissa K. Robbins Breakdown of academic impact, for papers by Angelo B. A. Laranjeira Breakdown of academic impact, for papers by Katharine H. Dixon Breakdown of academic impact, for papers by D. M. Moccio Breakdown of academic impact, for papers by O Babuŝíková Breakdown of academic impact, for papers by Yuri Yanishevski Breakdown of academic impact, for papers by WR Vogler Breakdown of academic impact, for papers by Carol A. Cucchi Breakdown of academic impact, for papers by Aglair B. Garcia Breakdown of academic impact, for papers by Sita Kugel Desmoulin
Rankless by CCL
2026